- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05355779
Needs Assessment to Guide the Development of a Paediatric Survivorship Programme in Hong Kong
Needs Assessment to Guide the Development of a Paediatric Survivorship Programme in Hong Kong to Promote Physical and Psychological Well-being of Children After Cancer Treatment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objectives: Although increasing attention has been devoted to the development of paediatric cancer survivorship programmes, most of these studies have originated in Western countries. Given the cultural differences between Asian and Western communities, the applicability of the findings to paediatric cancer survivors in Asian cultural contexts is limited. To date, research remains scant regarding the needs and challenges of Hong Kong Chinese paediatric cancer survivors and the key stakeholders involved during the transition period after cancer treatment. Although Hong Kong paediatric cancer survivors do attend regular medical follow-up visits, most attention has been focused on their physiological care, while their psychosocial needs remain unmet. Accordingly, the aim of this proposed study will be to fill the gaps in knowledge regarding the effects of cancer and its treatment, especially will focus on psychosocial effects in Hong Kong Chinese paediatric cancer survivors during the transition period.
Design and subjects: A qualitative descriptive design will be used. A purposive sample of 15 paediatric cancer survivor participants and their parents or caregivers, five paediatric oncology nurses and three paediatric oncologists will be invited for a semi-structured interview conducted with the aid of an interview guide.
Data analysis: A thematic analysis approach will be used for data analysis.
Expected results: The findings of this study will provide an in-depth understanding of the needs, challenges and views of paediatric cancer survivors and other key stakeholders, which will greatly facilitate the future development of appropriate targeted paediatric cancer survivorship programmes.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- The Hong Kong Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- able to speak Cantonese and read Chinese
- aged between 9 and 18 years of age
- Should have completed cancer treatment between 2 months and 2 years earlier
Exclusion Criteria:
- Children who received a diagnosis and completed treatment before the age of 9 will be excluded as they might have vague memories of the course of cancer and may have limited verbal and cognitive ability to express themselves
- Children of exclude parents will be exclueded
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Interviewees
Paediatric cancer survivors, their parent/caregiver and health care professionals will be invited to express their views and perspectives in an interview with the researcher
|
Not Application as this is a qualitative study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
An individual, a face-to-face interview will be conducted with the participants to identify the needs of paediatric cancer survivors during the transition period after cancer treatment
Time Frame: through study completion, an average of 15 months
|
Semi-structured and open-ended questions will be used to collect qualitative data from the participants
|
through study completion, an average of 15 months
|
|
An individual, a face-to-face interview will be conducted with the participants to assess the key elements in the development of a paediatric survivorship programme
Time Frame: through study completion, an average of 15 months
|
Semi-structured and open-ended questions will be used to collect qualitative data from the participants
|
through study completion, an average of 15 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Joyce Chung, Hong Kong Polytechnic University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HKCH-REC-2021-056
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cancer
-
Rigshospitalet, DenmarkDanish Cancer Society; Danish Child Cancer FoundationNot yet recruitingPediatric Cancer | Pediatric Cancer PatientsDenmark
-
Associazione Italiana Ematologia Oncologia PediatricaRecruitingRehabilitation | Pediatric Cancer | Physical Therapy | Pediatric Oncology | Pediatric Cancer Patients | Motor OutcomesItaly
-
Ann & Robert H Lurie Children's Hospital of ChicagoSilicon Valley Community FoundationCompletedCancer | Pediatric CancerUnited States
-
University of BirminghamCompletedCancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AMLUnited Kingdom, Australia, Netherlands
-
Emory UniversityNational Cancer Institute (NCI)Completed
-
Eskisehir Osmangazi UniversityNot yet recruitingPediatric Cancer | Resilience, Psychological | Mobile Application | Coping | Adolescent Cancer | Pediatric NursingTurkey (Türkiye)
-
University of Witten/HerdeckeHeidehof Foundation Stuttgart; Community Hospital Herdecke; Nordoff/Robbins Music... and other collaboratorsRecruiting
-
Afyonkarahisar Health Sciences UniversityRecruiting
-
University of California, San FranciscoWithdrawnPediatric CancerUnited States
-
KU LeuvenUniversitaire Ziekenhuizen KU Leuven; Research Foundation FlandersActive, not recruiting
Clinical Trials on Not Application as this is a qualitative study
-
The Hong Kong Polytechnic UniversityCompleted
-
Cambridge University Hospitals NHS Foundation TrustAstraZeneca; Cancer Research UK Cambridge InstituteRecruitingHigh-grade B-cell LymphomaUnited Kingdom
-
Satellite HealthcareCompleted
-
University College of Southeast NorwayExtrastiftelsenUnknown
-
King's College LondonCompleted
-
Medlior Health Outcomes Research LtdCompletedChronic Kidney Diseases | Type 2 Diabetes
-
Biosplice Therapeutics, Inc.Completed
-
Nicoline LøkkenCompleted